Simurosertib (TAK-931) is an orally active, selective and ATP-competitive cell division cycle 7 (CDC7) kinase inhibitor, with an IC50 of <0.3 nM. Simurosertib has anti-cancer activity.
Molecular Weight:
341.43
Purity:
>99%
CAS Number:
[1330782-76-7]
Target:
CDK
* VAT and and shipping costs not included. Errors and price changes excepted
